NCT04954651View on ClinicalTrials.gov

Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received EU-approved COVID-19 Vaccines

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 7, 2021

Primary Completion Date

March 28, 2022

Study Completion Date

March 28, 2022

Conditions
SARS-CoV2 InfectionVaccine Reaction
Interventions
BIOLOGICAL

Approved vaccines against Sars-Cov2

Subjects who voluntarily are vaccinated against Sars-Cov-2 with any of the approved vaccines by EU

Trial Locations (1)

26504

University Hospital of Patras, Pátrai

All Listed Sponsors
lead

University of Patras

OTHER